WellGen, Inc. is a privately financed company that received its first infusion of capital in 2000. Our lead investors are Rutgers University, UMDNJ (University of Medicine & Dentistry of New Jersey) and Amphion Innovations (AIM: AMP.L), a developer of new technology and life science businesses
North Brunswick, NJ–(BUSINESS WIRE)—WellGen, Inc. (www.wellgen.com), a private biotechnology company that is discovering and developing proprietary medical foods using nutrigenomics technology, announced that Dr. Roddy Carter, president and chief executive officer, will present [...]
Continue Reading...